STERIS (NYSE:STE) Raised to Strong-Buy at Wall Street Zen
Alpha Vantage · MarketBeat · · AI-summarised by FinFlash
Wall Street Zen has upgraded STERIS (NYSE:STE) from a "buy" to a "strong-buy" rating. This upgrade aligns with an overall "Moderate Buy" analyst sentiment and an average price target of $271.33 for the medical equipment provider. STERIS recently reported strong quarterly earnings, beating EPS estimates by $0.10 and achieving a 7.3% year-over-year revenue increase.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.